Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events

被引:25
|
作者
Simon, Tobias [1 ]
Becker, Ruediger [1 ]
Voss, Frederik [1 ]
Bikou, Olympia [1 ]
Hauck, Melanie [1 ]
Licka, Manuela [1 ]
Katus, Hugo A. [1 ]
Bauer, Alexander [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Cardiol, D-69120 Heidelberg, Germany
关键词
nonischemic cardiomyopathy; risk stratification; non sustained ventricular tachycardias; NT-pro BNP; sudden cardiac death;
D O I
10.1007/s00392-007-0629-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with nonischemic cardiomyopathy (DCM) are at high risk for sudden cardiac death (SCD). However, the predictive value of prophylactic implantation of implantable cardioverter defibrillators (ICD) in this patient cohort is yet unclear. Methods and Results: Whether NT pro BNP levels and/or reproducible non sustained ventricular tachycardias (NSVTs) are predictive for SCD was prospectively tested in 30 patients with DCM and LVEF <= 40%. All patients received Holter-recordings (HR) on three consecutive days and baseline NT-pro BNP levels were determined. Patients were followed for occurrence of ventricular tachyarrhythmias or unexplained syncope. A great degree of variability was found regarding the occurrence of NSVTs (10% had NSVTs in two consecutive HR, 10% in three consecutive HR, 30% in one HR and 50% had no NSVTs). Patients with NSVTs in more than one HR had significantly higher NT-pro BNP levels (first quartile: 715 pg/ml, median 2,176 pg/ml, third quartile 5,755 pg/ml vs. first quartile 273 pg/ml, median 566 pg/ml, third quartile 1,350 pg/ml, P = 0.0388). During a mean follow-up of 21.6 +/- 1.2 months patients with an arrhythmic event had significantly higher NT-pro BNP levels than patients without event (first quartile: 1,002 pg/ml, median 4,075 pg/ml, third quartile 7,777 pg/ml vs. first quartile 173 pg/ml, median 267 pg/ml, third quartile 1,220 pg/ml, P = 0.0135). NT-pro BNP levels of 2,259 pg/ml were identified as optimal cut-off value for the prediction of arrhythmic events (P = 0.0313). In contrast reproducible NSVTs were not predictive for arrhythmic events (P = 0.0960). Conclusion: The present study demonstrates that in patients with DCM the value of reproducible NSVTs in predicting arrhythmic events is low. In contrast raised NT-pro BNP levels significantly correlated with occurrence of symptomatic ventricular arrhythmias. Larger prospective trials are required to confirm these results.
引用
收藏
页码:306 / 309
页数:4
相关论文
共 50 条
  • [1] Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events
    Tobias Simon
    Ruediger Becker
    Frederik Voss
    Olympia Bikou
    Melanie Hauck
    Manuela Licka
    Hugo A. Katus
    Alexander Bauer
    Clinical Research in Cardiology, 2008, 97 : 306 - 309
  • [2] Elevated B-type Natriuretic Peptide Levels in Patients Undergoing Coronary Stenting
    Krishna, Abhay
    Kapoor, Aditya
    Kumar, Sudeep
    Tewari, Satyendra
    Garg, Naveen
    Goel, Pravin
    JOURNAL OF INVASIVE CARDIOLOGY, 2011, 23 (06): : 240 - 245
  • [3] Mathematical model to predict B-type natriuretic peptide levels in haemodialysis patients
    Touzot, Maxime
    Seris, Pascal
    Maheas, Catherine
    Vanmassenhove, Jill
    Langlois, Anne-Lyse
    Moubakir, Kamal
    Laplanche, Sophie
    Petitclerc, Thierry
    Ridel, Christophe
    Lavielle, Marc
    NEPHROLOGY, 2020, 25 (01) : 82 - 89
  • [4] Can the presence of an S3 predict elevated B-type natriuretic peptide levels?
    Marcus, GM
    Michaels, AD
    DeMarco, TA
    Chatterjee, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 143A - 143A
  • [5] Prognosis of Stage A or B Heart Failure Patients With Elevated B-type Natriuretic Peptide Levels
    Daniels, Lori B.
    Clopton, Paul
    Jiang, Kevin
    Greenberg, Barry
    Maisel, Alan S.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (02) : 93 - 98
  • [6] Association of elevated plasma B-type natriuretic peptide levels with paroxysmal atrial fibrillation in patients with nonobstructive hypertrophic cardiomyopathy
    Matsuura, Hiroko
    Murakami, Takashi
    Hina, Kazuyoshi
    Yamamoto, Keizo
    Kawamura, Hiroshi
    Sogo, Taiji
    Shinohata, Ryoko
    Usui, Shinichi
    Ninomiya, Yoshifumi
    Kusachi, Shozo
    CLINICAL BIOCHEMISTRY, 2008, 41 (03) : 134 - 139
  • [7] Predictors of absence of heart failure in patients with elevated B-type natriuretic peptide levels
    Knudsen, CW
    Clopton, P
    Klemsdal, TO
    Westheim, A
    Wu, A
    Abraham, WT
    Storrow, AB
    McCord, JK
    Nowak, RM
    McCullough, PA
    Omland, T
    CIRCULATION, 2004, 110 (17) : 368 - 368
  • [8] Evaluation of B-type natriuretic peptide (BNP) levels in patients at elevated risk for preeclampsia
    Whitcomb, E
    Resnik, J
    Moore, T
    Resnik, R
    Agent, S
    Beede, J
    Maisel, A
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (06) : S79 - S79
  • [9] Increased Left Ventricular Trabeculation Is Associated With Increased B-Type Natriuretic Peptide Levels and Impaired Outcomes in Nonischemic Cardiomyopathy
    Kawamura, Takayuki
    Yasuda, Masakazu
    Okune, Mana
    Kakehi, Kazuyoshi
    Kagioka, Yoshinori
    Nakamura, Takashi
    Miyazaki, Shunichi
    Iwanaga, Yoshitaka
    CANADIAN JOURNAL OF CARDIOLOGY, 2020, 36 (04) : 518 - 526
  • [10] Elevated B-type natriuretic peptide levels after anthracycline administration
    Suzuki, T
    Hayashi, D
    Yamazaki, T
    Mizuno, T
    Kanda, Y
    Komuro, I
    Kurabayashi, M
    Yamaoki, K
    Mitani, K
    Hirai, H
    Nagai, R
    Yazaki, Y
    AMERICAN HEART JOURNAL, 1998, 136 (02) : 362 - 363